Related items

Pfizer selected Denmark as the site of the largest vaccine registry study ever undertaken, demonstrating how Europe can attract world-leading life sciences investment when the right conditions are in place. Beginning in 2024, Pfizer partnered with researchers at the Center for Translational Cardiology and Pragmatic Randomized Trials at Herlev-Gentofte Hospital in Copenhagen to assess whether its respiratory syncytial virus vaccine could reduce hospitalisations in adults. Denmark’s innovation-friendly environment, national digital mailbox eBoks and world-class health registries enabled researchers to invite almost the entire adult population to take part, helping recruit more than 500,000 participants. Study materials were made available online, allowing participants to provide informed consent from home, while health registries supported comprehensive tracking and analysis. This milestone shows how strong public-private collaboration and a supportive policy framework can help Europe deliver clinical research at scale and improve health outcomes for citizens. Read the full story on Invested in Europe. 

From Tuesday, 16 to Wednesday, 17 June, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings on EU trade and external affairs policy developments. The delegation engaged with Members of the European Parliament and political group advisers to share business perspectives on the future of the EU-US relationship. Discussions focused on the need to reset transatlantic trade and investment ties, strengthen Europe’s competitiveness and preserve open, rules-based markets. Members also highlighted the importance of avoiding tariffs, reducing regulatory complexity, deepening cooperation on economic security, critical supply chains and digital policy as well as ensuring that resilience measures remain proportionate, predictable and open to trusted partners.

On Tuesday, 10 June, Thibaut L’Ortye spoke at EUROPEN’s panel on Global Partnerships and the EU Single Market. The discussion focused on how Europe can strengthen its competitiveness and attractiveness as an investment destination. Mr L’Ortye underlined the importance of external partnerships to support supply chains, particularly in areas such as critical minerals and AI, as well as secondary raw materials. He also highlighted the need for the EU to remain open to international investors while pursuing its economic security objectives.